How will the ADC sector fair in 2020 and beyond?

Do pharma mergers and acquisitions improve R&D productivity and increase shareholder value?

How is the business of making medicine changing in light of the COVID-19 pandemic?

Manufacturers have a unique opportunity to take advantage of the cost and time advantages associated with Oligo(dT) – the adoption process is simple.

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.

How can nanotechnology be used to deliver drugs through the skin?

It’s time to address the bottlenecks that lie in quality assurance review and release – and digital systems can help.

Why finding new talent is crucial to the success of the cell and gene therapy industry.

How can salivary proteins derived from ticks help treat COVID-19?

Experts from the UK discuss how the country is tackling the CGT skills gap.